Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population.

Higgins RS, Brown RN, Chang PP, Starling RC, Ewald GA, Tallaj JA, Kirklin JK, George JF.

J Heart Lung Transplant. 2014 May;33(5):478-85. doi: 10.1016/j.healun.2014.01.862. Epub 2014 Jan 28.

PMID:
24630406
2.

A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening.

Johnson EE, Leverson GE, Pirsch JD, Heise CP.

J Gastrointest Surg. 2007 Mar;11(3):272-9.

PMID:
17458597
3.

Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.

Kellerman L, Neugut A, Burke B, Mancini D.

Am J Cardiol. 2009 Feb 15;103(4):562-6. doi: 10.1016/j.amjcard.2008.10.026. Epub 2008 Dec 26.

PMID:
19195521
4.

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.

Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):406-14.

PMID:
11872286
5.

Malignancy after heart transplantation: analysis of 24-year experience at a single center.

Yagdi T, Sharples L, Tsui S, Large S, Parameshwar J.

J Card Surg. 2009 Sep-Oct;24(5):572-9. doi: 10.1111/j.1540-8191.2009.00858.x. Epub 2009 May 28.

PMID:
19486222
6.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
7.

Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience.

Roithmaier S, Haydon AM, Loi S, Esmore D, Griffiths A, Bergin P, Williams TJ, Schwarz MA.

J Heart Lung Transplant. 2007 Aug;26(8):845-9.

PMID:
17692790
8.

Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.

Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, Rutgrink E, Ramsoebhag A, Hop A, Persijn G, Laufer G.

Clin Transpl. 2003:89-100.

PMID:
15387100
9.

Risk of malignancy with long-term immunosuppression in renal transplant recipients.

Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB.

Kidney Int. 2004 Jul;66(1):383-9.

10.

Post-transplant malignancy in liver transplantation: a single center experience.

Hsiao CY, Lee PH, Ho CM, Wu YM, Ho MC, Hu RH.

Medicine (Baltimore). 2014 Dec;93(28):e310. doi: 10.1097/MD.0000000000000310. Erratum in: Medicine (Baltimore). 2015 Jan;94(1):1.

11.

Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?

Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ Jr.

Cancer. 1997 Jun 15;79(12):2409-13.

PMID:
9191531
12.

Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.

Hubbard MO, Fu P, Margevicius S, Dowlati A, Linden PA.

J Thorac Cardiovasc Surg. 2012 Jun;143(6):1307-13. doi: 10.1016/j.jtcvs.2012.01.078. Epub 2012 Feb 22.

13.

The development of breast carcinoma in women with thyroid carcinoma.

Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, Vassilopoulou-Sellin R.

Cancer. 2001 Jul 15;92(2):225-31.

PMID:
11466673
14.

Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report.

Lin HM, Kauffman HM, McBride MA, Davies DB, Rosendale JD, Smith CM, Edwards EB, Daily OP, Kirklin J, Shield CF, Hunsicker LG.

JAMA. 1998 Oct 7;280(13):1153-60.

PMID:
9777815
15.

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.

Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, Rakela J, Irish W, Fung JJ.

Transplantation. 1998 Nov 15;66(9):1193-200.

PMID:
9825817
17.

Preoperative risk factors predict survival following cardiac retransplantation: analysis of the United Network for Organ Sharing database.

Belli E, Leoni Moreno JC, Hosenpud J, Rawal B, Landolfo K.

J Thorac Cardiovasc Surg. 2014 Jun;147(6):1972-7, 1977.e1. doi: 10.1016/j.jtcvs.2014.02.013. Epub 2014 Feb 12.

18.

Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP.

J Natl Cancer Inst. 2010 Jul 21;102(14):1083-95. doi: 10.1093/jnci/djq238. Epub 2010 Jul 15.

19.

Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group.

Kirklin JK, Naftel DC, Levine TB, Bourge RC, Pelletier GB, O'Donnell J, Miller LW, Pritzker MR.

J Heart Lung Transplant. 1994 May-Jun;13(3):394-404.

PMID:
8061014
20.

Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.

Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, Shah T.

Transplantation. 2012 Nov 27;94(10):990-8. doi: 10.1097/TP.0b013e318270bc7b.

PMID:
23085553
Items per page

Supplemental Content

Write to the Help Desk